Descriptions

The mammalian fibroblast growth factor (FGF)1 family contains at least 22 distinct polypeptides (FGF1–FGF22) that are expressed in a specific spatial and temporal pattern. FGF9 was originally described as a glia-activating factor and is expressed in the nervous system as a potent mitogen for glia cells. FGF9 adopts a beta-trefoil fold similar to other FGFs, but the N- and C-terminal regions outside the beta-trefoil core are ordered (typical FGFs have disordered tails) and involved in reversible dimerization. Due to the dimerization, a significant surface area is buried in the dimer interface that occludes a major receptor binding site of FGF9 within the beta-trefoil core.

Autoinhibitory domains (AIDs)

Target domain

66-193 (beta-trefoil core)

Relief mechanism

Assay

Target domain

66-193 (beta-trefoil core)

Relief mechanism

Assay

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

2 structures for Q9NP95

Entry ID Method Resolution Chain Position Source
3F1R X-ray 250 A A/B 1-211 PDB
AF-Q9NP95-F1 Predicted AlphaFoldDB

344 variants for Q9NP95

Variant ID(s) Position Change Description Diseaes Association Provenance
RCV000114397
CA151162
rs587777282
113 V>missing Renal hypodysplasia/aplasia 2 [ClinVar] Yes ClinGen
ClinVar
dbSNP
rs1384485178 2 A>P No TOPMed
rs1266965416 2 A>V No gnomAD
rs1456038983 3 P>S No TOPMed
rs866476790 5 A>S No Ensembl
rs774980310 6 E>D No TOPMed
gnomAD
rs1810201095 7 V>A No Ensembl
rs1328342914 8 G>A No gnomAD
rs1236847607 8 G>R No TOPMed
gnomAD
rs764133199 9 G>A No ExAC
TOPMed
gnomAD
rs764133199 9 G>D No ExAC
TOPMed
gnomAD
rs971587907 9 G>S No TOPMed
gnomAD
rs764133199 9 G>V No ExAC
TOPMed
gnomAD
rs1382423605 10 F>L No gnomAD
rs1386560941 10 F>Y No TOPMed
gnomAD
rs1810200476 11 L>P No TOPMed
rs761291744 13 G>C No ExAC
gnomAD
RCV002009976
rs940371952
13 G>D No ClinVar
TOPMed
dbSNP
gnomAD
rs761291744 13 G>R No ExAC
gnomAD
rs940371952 13 G>V No TOPMed
gnomAD
rs890122801 15 E>D No gnomAD
rs563056645 16 G>V No 1000Genomes
ExAC
gnomAD
rs1198490956 18 G>R No gnomAD
rs774802384 19 Q>R No ExAC
TOPMed
gnomAD
rs1263989325 20 Q>* No gnomAD
rs1263989325 20 Q>E No gnomAD
rs368189425 20 Q>L No ESP
ExAC
TOPMed
gnomAD
rs1810199636 21 V>M No TOPMed
gnomAD
rs1810199516 22 G>D No Ensembl
rs2150437425 23 S>* No Ensembl
rs1695692722 24 H>N No gnomAD
rs1201636021 24 H>Q No TOPMed
rs1321230475 26 L>P No gnomAD
rs1327787964 27 L>F Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
TOPMed
gnomAD
rs997382058 28 P>L No TOPMed
gnomAD
rs1040301036 28 P>T No TOPMed
gnomAD
rs1471698032 29 P>A No TOPMed
gnomAD
rs936160285 29 P>L No TOPMed
gnomAD
rs936160285 29 P>R No TOPMed
gnomAD
rs1471698032 29 P>S No TOPMed
gnomAD
rs1471698032 29 P>T No TOPMed
gnomAD
rs1388551553 30 A>T No TOPMed
gnomAD
rs748157916 30 A>V No ExAC
TOPMed
gnomAD
rs781139228 31 G>A No ExAC
TOPMed
gnomAD
rs1810198621 31 G>R No TOPMed
gnomAD
rs781139228 31 G>V No ExAC
TOPMed
gnomAD
rs754861005 32 E>* No ExAC
TOPMed
gnomAD
rs754861005 32 E>K No ExAC
TOPMed
gnomAD
rs754861005 32 E>Q No ExAC
TOPMed
gnomAD
rs560178950 33 R>G No 1000Genomes
ExAC
TOPMed
gnomAD
rs1333634965 33 R>L No TOPMed
gnomAD
rs1333634965 33 R>P No TOPMed
gnomAD
rs560178950 33 R>W No 1000Genomes
ExAC
TOPMed
gnomAD
rs1374947340 34 P>A No TOPMed
gnomAD
rs1374947340 34 P>S No TOPMed
gnomAD
RCV000722376
rs1563235398
34 P>T No ClinVar
Ensembl
dbSNP
rs1253072793 35 P>L Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
TOPMed
gnomAD
rs1253072793 35 P>Q No TOPMed
gnomAD
rs1253072793 35 P>R No TOPMed
gnomAD
rs1322607102 35 P>S No TOPMed
gnomAD
rs1810197668 36 L>P No TOPMed
gnomAD
rs1205538550 37 L>P No TOPMed
gnomAD
rs1205538550 37 L>Q No TOPMed
gnomAD
rs1205538550 37 L>R No TOPMed
gnomAD
rs1196466631 38 G>D No Ensembl
rs1459900849 38 G>R No gnomAD
rs2150437389 39 E>G No Ensembl
rs1007752081 39 E>Q No TOPMed
gnomAD
rs1341053895 40 R>H No TOPMed
gnomAD
rs1341053895 40 R>L No TOPMed
gnomAD
rs892902237 41 R>G No TOPMed
gnomAD
rs758127072 41 R>S No ExAC
gnomAD
rs892902237 41 R>W No TOPMed
gnomAD
rs1201801919 42 S>G No TOPMed
rs1382953827 42 S>I No TOPMed
gnomAD
rs917244560 42 S>R No TOPMed
gnomAD
rs1382953827 42 S>T No TOPMed
gnomAD
rs1455087624 43 A>E No TOPMed
gnomAD
rs1455087624 43 A>G No TOPMed
gnomAD
rs1054572439 43 A>T No TOPMed
gnomAD
rs1304104955 44 A>T No gnomAD
rs750018995 45 E>A No 1000Genomes
ExAC
TOPMed
gnomAD
rs750018995 45 E>G No 1000Genomes
ExAC
TOPMed
gnomAD
rs1389722667 45 E>K No TOPMed
gnomAD
rs1034419442 46 R>L No 1000Genomes
TOPMed
gnomAD
rs1034419442 46 R>P No 1000Genomes
TOPMed
gnomAD
rs1034419442 46 R>Q No 1000Genomes
TOPMed
gnomAD
rs764839951 46 R>W No ExAC
TOPMed
gnomAD
rs1429324991 47 S>G No gnomAD
rs1385984646 47 S>I No TOPMed
gnomAD
rs1385984646 47 S>N No TOPMed
gnomAD
rs112761348 47 S>R No TOPMed
gnomAD
rs1236770327 48 A>G No TOPMed
gnomAD
rs1442725564 48 A>P No TOPMed
gnomAD
rs1442725564 48 A>S No TOPMed
gnomAD
rs1442725564 48 A>T No TOPMed
gnomAD
rs1236770327 48 A>V No TOPMed
gnomAD
rs1014889171 49 R>C No 1000Genomes
TOPMed
gnomAD
rs1014889171 49 R>G No 1000Genomes
TOPMed
gnomAD
rs768155803 49 R>H No ExAC
gnomAD
rs768155803 49 R>L No ExAC
gnomAD
rs1014889171 49 R>S No 1000Genomes
TOPMed
gnomAD
rs774926782 50 G>A No ExAC
TOPMed
gnomAD
rs760057737 50 G>C No ExAC
TOPMed
gnomAD
rs774926782 50 G>D No ExAC
TOPMed
gnomAD
rs760057737 50 G>S No ExAC
TOPMed
gnomAD
rs763286912 51 G>E No ExAC
TOPMed
gnomAD
rs1354870466 51 G>R No TOPMed
gnomAD
rs763286912 51 G>V No ExAC
TOPMed
gnomAD
rs1354870466 51 G>W No TOPMed
gnomAD
rs1337956675 52 P>A No TOPMed
gnomAD
rs770019188 52 P>Q No ExAC
TOPMed
gnomAD
rs770019188 52 P>R No ExAC
TOPMed
gnomAD
rs1337956675 52 P>S No TOPMed
gnomAD
rs557790865 53 G>A No 1000Genomes
TOPMed
gnomAD
rs557790865 53 G>E No 1000Genomes
TOPMed
gnomAD
rs1810195185 54 A>D No Ensembl
rs544089387 54 A>S No 1000Genomes
TOPMed
gnomAD
rs544089387 54 A>T No 1000Genomes
TOPMed
gnomAD
rs1053462209 55 A>E No 1000Genomes
TOPMed
rs991685834 55 A>S No TOPMed
gnomAD
rs991685834 55 A>T No TOPMed
gnomAD
rs748250152 56 Q>H No ExAC
TOPMed
gnomAD
rs1810194976 56 Q>K No TOPMed
rs1471106247 56 Q>L No TOPMed
gnomAD
rs1471106247 56 Q>P No TOPMed
gnomAD
rs1490416114 57 L>P No gnomAD
rs1181132258 57 L>V No TOPMed
gnomAD
rs776625873 58 A>E No ExAC
gnomAD
rs1554495374 58 A>S No gnomAD
rs776625873 58 A>V No ExAC
gnomAD
rs1321356073 59 H>P No TOPMed
gnomAD
rs1810194256 59 H>Q No Ensembl
rs1255003610 61 H>N No gnomAD
rs746934075 61 H>Q No ExAC
TOPMed
gnomAD
rs779946155 62 G>C No ExAC
TOPMed
gnomAD
rs1353422098 62 G>D No TOPMed
gnomAD
rs779946155 62 G>R No ExAC
TOPMed
gnomAD
rs779946155 62 G>S No ExAC
TOPMed
gnomAD
rs1286870556 63 I>F No gnomAD
rs1286870556 63 I>V No gnomAD
rs926128321 66 R>C No TOPMed
gnomAD
rs745633361 67 R>G No ExAC
TOPMed
gnomAD
rs778448883 67 R>P No ExAC
TOPMed
gnomAD
rs778448883 67 R>Q No ExAC
TOPMed
gnomAD
rs745633361 67 R>W No ExAC
TOPMed
gnomAD
rs1384031505 70 Y>N No TOPMed
gnomAD
rs917482390 70 Y>S No Ensembl
rs993260184 71 C>G No Ensembl
rs1810193077 71 C>Y No gnomAD
rs1421713806 72 R>G No TOPMed
gnomAD
rs753406405 72 R>H No ExAC
TOPMed
gnomAD
rs753406405 72 R>L No ExAC
TOPMed
gnomAD
rs1402401757 73 T>A No gnomAD
rs1810192793 74 G>A No TOPMed
rs1810192793 74 G>D No TOPMed
rs1810192544 75 F>L No TOPMed
rs1480681473 75 F>S No gnomAD
rs1810192394 77 L>P No TOPMed
rs1189147785 77 L>V No gnomAD
rs112951749 78 Q>E No TOPMed
gnomAD
rs535724491 78 Q>H No 1000Genomes
ExAC
TOPMed
gnomAD
rs112951749 78 Q>K No TOPMed
gnomAD
rs1242227215 78 Q>R No gnomAD
rs1266708845 79 I>M Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
TOPMed
gnomAD
RCV000908702
rs377326763
79 I>V No ClinVar
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs1810191840 80 L>Q No Ensembl
rs1324785887 81 P>H No gnomAD
rs1324785887 81 P>R No gnomAD
rs1208644279 81 P>S No TOPMed
gnomAD
rs1208644279 81 P>T No TOPMed
gnomAD
rs1810191448 82 D>E No TOPMed
rs1451460296 82 D>N No gnomAD
rs553747126 83 G>D No 1000Genomes
ExAC
gnomAD
rs951419835 83 G>R No TOPMed
gnomAD
rs533886836 84 S>N No 1000Genomes
ExAC
TOPMed
gnomAD
rs1473311716 84 S>R No gnomAD
rs533886836 84 S>T No 1000Genomes
ExAC
TOPMed
gnomAD
rs1415184585 85 V>L No gnomAD
rs776748782 86 Q>H No ExAC
gnomAD
rs1270861983 86 Q>R No gnomAD
TCGA novel 87 G>D Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs571418438 88 T>A No 1000Genomes
ExAC
gnomAD
rs760643638 88 T>I No ExAC
gnomAD
rs1228175652 89 R>Q No TOPMed
gnomAD
rs1408079162 89 R>W No gnomAD
rs1173650694 90 Q>* Variant assessed as Somatic; HIGH impact. [NCI-TCGA] No NCI-TCGA
gnomAD
rs1203769902 90 Q>H No gnomAD
rs1419715913 91 D>E No gnomAD
rs1432260518 91 D>N No gnomAD
rs771993864 92 H>P No ExAC
TOPMed
gnomAD
rs1810190165 92 H>Q No TOPMed
rs771993864 92 H>R No ExAC
TOPMed
gnomAD
rs1187766235 92 H>Y No TOPMed
gnomAD
rs745659538 93 S>G No ExAC
TOPMed
gnomAD
rs1208700823 93 S>N No gnomAD
rs770778026 94 L>I No ExAC
gnomAD
rs1554495355 94 L>R No Ensembl
rs777477639 95 F>L No ExAC
gnomAD
rs1274066944 96 G>C No TOPMed
gnomAD
rs1274066944 96 G>R No TOPMed
gnomAD
TCGA novel 97 I>M Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs370758961 98 L>W No ESP
ExAC
gnomAD
rs774317326 99 E>G No ExAC
gnomAD
TCGA novel 100 F>C Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs1021365248 101 I>V No TOPMed
rs1308905635 103 V>M No TOPMed
gnomAD
rs1810027774 104 A>G No TOPMed
rs766380961 104 A>S No ExAC
gnomAD
rs1449412678 105 V>M No TOPMed
rs1810027644 106 G>R No Ensembl
COSM4919443 107 L>M Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs766382683 107 L>P No ExAC
gnomAD
rs766382683 107 L>Q No ExAC
gnomAD
rs1162134925 108 V>I No TOPMed
gnomAD
rs1162134925 108 V>L No TOPMed
gnomAD
rs1376376754 109 S>T No TOPMed
rs367661392 110 I>V No ESP
ExAC
TOPMed
gnomAD
rs769576140 111 R>S No ExAC
gnomAD
rs1810027190 112 G>D No gnomAD
rs1292395727 112 G>S No gnomAD
rs747822150 113 V>M No ExAC
TOPMed
gnomAD
rs1161832443 114 D>G No gnomAD
rs768178900 116 G>D No ExAC
gnomAD
RCV000912224
VAR_020946
rs3793405
116 G>R No ClinVar
UniProt
1000Genomes
ExAC
TOPMed
dbSNP
gnomAD
rs1810026731 117 L>V No Ensembl
rs746460841 118 Y>D No ExAC
gnomAD
rs532205949 120 G>A No 1000Genomes
ExAC
gnomAD
rs1486159825 120 G>R No TOPMed
gnomAD
rs1328283813 121 M>I Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
TOPMed
gnomAD
rs1283655289 122 N>S No gnomAD
COSM232338 125 G>E Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
COSM3646844 125 G>R Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs1040608226 125 G>V No TOPMed
gnomAD
rs563540999 127 L>F No 1000Genomes
ExAC
gnomAD
rs1810025981 127 L>R No Ensembl
rs1323206170 130 S>L No gnomAD
rs765043985 131 E>D Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ExAC
NCI-TCGA
TOPMed
gnomAD
COSM3898467 133 L>P Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
COSM3898466 133 L>R Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs761688715 133 L>V No ExAC
TOPMed
gnomAD
rs1323039427 134 T>S No Ensembl
rs200152641 135 S>C No 1000Genomes
ExAC
TOPMed
gnomAD
rs200152641 135 S>F No 1000Genomes
ExAC
TOPMed
gnomAD
rs201317229
COSM174439
136 E>K Variant assessed as Somatic; MODERATE impact. large_intestine [NCI-TCGA, Cosmic] No NCI-TCGA Cosmic
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1450792723 137 C>R No gnomAD
COSM6112877 138 I>F Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs1339121613 138 I>M No gnomAD
rs1809959923 138 I>V No Ensembl
rs775035654 139 F>L No ExAC
gnomAD
rs763495311 140 R>G No ExAC
TOPMed
gnomAD
rs773742854 140 R>K No ExAC
TOPMed
gnomAD
rs1306266506 140 R>S No gnomAD
rs773742854 140 R>T No ExAC
TOPMed
gnomAD
COSM3646843 141 E>K Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs1429266748 141 E>Q No TOPMed
gnomAD
COSM3367264
rs1385931006
142 Q>E kidney [Cosmic] No cosmic curated
gnomAD
rs1336185318 142 Q>H No TOPMed
rs1164980372 142 Q>R No gnomAD
rs1563231817 144 E>D No Ensembl
COSM181903 145 E>D Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs1209744626 148 Y>C No TOPMed
COSM3898465 148 Y>H Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs1809958580 149 N>I No gnomAD
rs770153930 149 N>K No ExAC
gnomAD
rs748560461 150 T>S No ExAC
TOPMed
gnomAD
rs1249076606 153 S>C No gnomAD
rs768990128 155 I>R No ExAC
TOPMed
gnomAD
rs780320172 156 Y>H No ExAC
TOPMed
gnomAD
rs750479279 157 K>E No ExAC
TOPMed
gnomAD
rs1283992489 157 K>N No gnomAD
rs1585100241 158 H>L No Ensembl
rs1229326644 161 T>A No gnomAD
rs757072657 161 T>I No ExAC
gnomAD
rs757072657 161 T>N No ExAC
gnomAD
rs143400495 162 G>S No ESP
ExAC
gnomAD
COSM486240
rs1325559004
163 R>C kidney Variant assessed as Somatic; MODERATE impact. [Cosmic, NCI-TCGA] No NCI-TCGA Cosmic
cosmic curated
NCI-TCGA
TOPMed
gnomAD
rs1325559004 163 R>G No TOPMed
gnomAD
rs760365627 163 R>H Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No ExAC
NCI-TCGA
TOPMed
gnomAD
rs760365627 163 R>L No ExAC
TOPMed
gnomAD
rs752318885 164 R>K No ExAC
gnomAD
rs767120553 164 R>S No ExAC
TOPMed
gnomAD
rs1161426917 166 F>L No TOPMed
rs759071753 166 F>S No ExAC
gnomAD
TCGA novel 168 A>H Variant assessed as Somatic; HIGH impact. [NCI-TCGA] No NCI-TCGA
rs1563231775 168 A>V No TOPMed
rs1809957044 169 L>F No TOPMed
rs773678490 170 N>S No ExAC
gnomAD
rs1809956855 171 K>N No TOPMed
rs770340289 171 K>R No ExAC
gnomAD
rs762222483 172 D>G No ExAC
TOPMed
gnomAD
rs762222483 172 D>V No ExAC
TOPMed
gnomAD
rs1252960774 173 G>R No gnomAD
rs1051138244 174 T>A No Ensembl
VAR_020947
rs10089600
175 P>A No UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs772360437 175 P>L No ExAC
TOPMed
gnomAD
rs772360437 175 P>Q No ExAC
TOPMed
gnomAD
rs10089600 175 P>T No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
COSM1699756
rs1809956313
176 R>K skin [Cosmic] No cosmic curated
TOPMed
COSM3374838 177 D>G Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA Cosmic
rs1360206014 177 D>H No TOPMed
gnomAD
rs2150433589 178 G>C No Ensembl
TCGA novel 178 G>D Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
rs376046538 179 A>S No ExAC
TOPMed
gnomAD
rs376046538 179 A>T No ExAC
TOPMed
gnomAD
rs749155129 180 R>S No ExAC
TOPMed
gnomAD
rs921238581 181 S>T No Ensembl
rs1809955799
COSM332163
182 K>N lung [Cosmic] No cosmic curated
gnomAD
rs1368510325 182 K>R No gnomAD
rs755939016 183 R>G No ExAC
TOPMed
gnomAD
rs753990768 183 R>K No ExAC
TOPMed
gnomAD
rs753990768 183 R>M No ExAC
TOPMed
gnomAD
rs767173525 183 R>S No ExAC
TOPMed
gnomAD
rs1809955393 184 H>R No TOPMed
rs556236317 185 Q>H No 1000Genomes
ExAC
gnomAD
rs1809955191 188 T>A No TOPMed
gnomAD
rs1809955148 189 H>D No Ensembl
rs1458723028 189 H>Q No gnomAD
rs762432192 191 L>F No ExAC
TOPMed
gnomAD
rs777035608 192 P>A No ExAC
gnomAD
rs1426756966 192 P>R No gnomAD
rs764646776 194 P>L No ExAC
gnomAD
rs764646776
COSM1252411
194 P>Q oesophagus [Cosmic] No cosmic curated
ExAC
gnomAD
rs376283820 195 V>E No ESP
ExAC
TOPMed
gnomAD
rs1212546905 195 V>L No TOPMed
gnomAD
rs1809953511 197 P>S No TOPMed
rs936045906 201 P>S No TOPMed
gnomAD
rs936045906
TCGA novel
201 P>T Variant assessed as Somatic; MODERATE impact. [NCI-TCGA] No NCI-TCGA
TOPMed
gnomAD
rs1208432532 203 L>M No TOPMed
gnomAD
rs1281074178 204 Y>C No gnomAD
rs372796901 204 Y>H No ESP
ExAC
TOPMed
gnomAD
rs774535729 205 K>E No ExAC
gnomAD
VAR_020948
RCV000965770
rs17550360
206 D>N No ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs17550360 206 D>Y No 1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1365472443 208 L>P No TOPMed
gnomAD
rs747943357 209 M>L No ExAC
TOPMed
gnomAD
rs1319650178 209 M>R No gnomAD
rs747943357 209 M>V No ExAC
TOPMed
gnomAD
rs780961429 210 Y>H No ExAC
gnomAD
rs573963889 211 T>A No 1000Genomes
ExAC
TOPMed
gnomAD
rs375846209 211 T>N No ESP
ExAC
TOPMed
gnomAD
rs573963889 211 T>P No 1000Genomes
ExAC
TOPMed
gnomAD
rs375846209 211 T>S No ESP
ExAC
TOPMed
gnomAD
rs1809952434 212 T>S No TOPMed

1 associated diseases with Q9NP95

[MIM: 615721]: Renal hypodysplasia/aplasia 2 (RHDA2)

A perinatally lethal renal disease encompassing a spectrum of kidney development defects, including renal agenesis, bilateral renal aplasia, hypoplasia, (cystic) dysplasia, and severe obstructive uropathy. . Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A perinatally lethal renal disease encompassing a spectrum of kidney development defects, including renal agenesis, bilateral renal aplasia, hypoplasia, (cystic) dysplasia, and severe obstructive uropathy. . Note=The disease is caused by variants affecting the gene represented in this entry.

7 regional properties for Q9NP95

Type Name Position InterPro Accession
domain Protein kinase domain 217 - 485 IPR000719
domain SH2 domain 112 - 205 IPR000980
domain Serine-threonine/tyrosine-protein kinase, catalytic domain 218 - 473 IPR001245
active_site Tyrosine-protein kinase, active site 340 - 352 IPR008266
binding_site Protein kinase, ATP binding site 223 - 250 IPR017441
domain Tyrosine-protein kinase, catalytic domain 217 - 475 IPR020635
domain Fes/Fps/Fer, SH2 domain 109 - 195 IPR035849

Functions

Description
EC Number
Subcellular Localization
  • Secreted
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
cytoplasm The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
extracellular region The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
extracellular space That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.

5 GO annotations of molecular function

Name Definition
fibroblast growth factor receptor binding Binding to a fibroblast growth factor receptor (FGFR).
growth factor activity The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation.
heparan sulfate proteoglycan binding Binding to a heparan sulfate proteoglycan, any proteoglycan containing heparan sulfate as the glycosaminoglycan carbohydrate unit.
receptor-receptor interaction The aggregation, arrangement and bonding together of two or more different receptor complexes that individually undergo combination with a hormone, neurotransmitter, drug or intracellular messenger to form a higher level receptor complex. The formation of the higher level complex initiates a change in cell function.
signaling receptor binding Binding to one or more specific sites on a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.

15 GO annotations of biological process

Name Definition
animal organ morphogenesis Morphogenesis of an animal organ. An organ is defined as a tissue or set of tissues that work together to perform a specific function or functions. Morphogenesis is the process in which anatomical structures are generated and organized. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.
cell differentiation The cellular developmental process in which a relatively unspecialized cell, e.g. embryonic or regenerative cell, acquires specialized structural and/or functional features that characterize a specific cell. Differentiation includes the processes involved in commitment of a cell to a specific fate and its subsequent development to the mature state.
cell-cell signaling Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
fibroblast growth factor receptor signaling pathway The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
inner ear auditory receptor cell differentiation The process in which a relatively unspecialized inner cell acquires specialized features of an auditory hair cell.
negative regulation of neuron apoptotic process Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
positive regulation of cell population proliferation Any process that activates or increases the rate or extent of cell proliferation.
positive regulation of dopaminergic neuron differentiation Any process that activates or increases the frequency, rate or extent of dopaminergic neuron differentiation.
positive regulation of ERK1 and ERK2 cascade Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
positive regulation of gene expression Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA).
positive regulation of protein phosphorylation Any process that activates or increases the frequency, rate or extent of addition of phosphate groups to amino acids within a protein.
regulation of cardiac muscle cell proliferation Any process that modulates the frequency, rate or extent of cardiac muscle cell proliferation.
regulation of cell migration Any process that modulates the frequency, rate or extent of cell migration.
regulation of dopamine secretion Any process that modulates the frequency, rate or extent of the regulated release of dopamine.
signal transduction The cellular process in which a signal is conveyed to trigger a change in the activity or state of a cell. Signal transduction begins with reception of a signal (e.g. a ligand binding to a receptor or receptor activation by a stimulus such as light), or for signal transduction in the absence of ligand, signal-withdrawal or the activity of a constitutively active receptor. Signal transduction ends with regulation of a downstream cellular process, e.g. regulation of transcription or regulation of a metabolic process. Signal transduction covers signaling from receptors located on the surface of the cell and signaling via molecules located within the cell. For signaling between cells, signal transduction is restricted to events at and within the receiving cell.

28 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
P48801 FGF3 Fibroblast growth factor 3 Gallus gallus (Chicken) SS
O15520 FGF10 Fibroblast growth factor 10 Homo sapiens (Human) SS
O43320 FGF16 Fibroblast growth factor 16 Homo sapiens (Human) EV SS
P10767 FGF6 Fibroblast growth factor 6 Homo sapiens (Human) SS
P11487 FGF3 Fibroblast growth factor 3 Homo sapiens (Human) SS
P31371 FGF9 Fibroblast growth factor 9 Homo sapiens (Human) EV
Q92914 FGF11 Fibroblast growth factor 11 Homo sapiens (Human) SS
Q9HCT0 FGF22 Fibroblast growth factor 22 Homo sapiens (Human) SS
Q9NSA1 FGF21 Fibroblast growth factor 21 Homo sapiens (Human) PR
P08620 FGF4 Fibroblast growth factor 4 Homo sapiens (Human) PR
P21658 Fgf6 Fibroblast growth factor 6 Mus musculus (Mouse) SS
Q9ESS2 Fgf22 Fibroblast growth factor 22 Mus musculus (Mouse) SS
O35565 Fgf10 Fibroblast growth factor 10 Mus musculus (Mouse) SS
P54130 Fgf9 Fibroblast growth factor 9 Mus musculus (Mouse) SS
Q9JJN1 Fgf21 Fibroblast growth factor 21 Mus musculus (Mouse) PR
Q9ESL8 Fgf16 Fibroblast growth factor 16 Mus musculus (Mouse) SS
P11403 Fgf4 Fibroblast growth factor 4 Mus musculus (Mouse) PR
P61329 Fgf12 Fibroblast growth factor 12 Mus musculus (Mouse) PR
P05524 Fgf3 Fibroblast growth factor 3 Mus musculus (Mouse) SS
Q9ESL9 Fgf20 Fibroblast growth factor 20 Mus musculus (Mouse) SS
Q95L12 FGF9 Fibroblast growth factor 9 Sus scrofa (Pig) SS
O54769 Fgf16 Fibroblast growth factor 16 Rattus norvegicus (Rat) SS
P36364 Fgf9 Fibroblast growth factor 9 Rattus norvegicus (Rat) SS
P70492 Fgf10 Fibroblast growth factor 10 Rattus norvegicus (Rat) SS
Q9EST9 Fgf20 Fibroblast growth factor 20 Rattus norvegicus (Rat) SS
Q6PBT8 fgf1 Putative fibroblast growth factor 1 Danio rerio (Zebrafish) (Brachydanio rerio) SS
Q2HXK8 fgf16 Fibroblast growth factor 16 Danio rerio (Zebrafish) (Brachydanio rerio) SS
P48802 fgf3 Fibroblast growth factor 3 Danio rerio (Zebrafish) (Brachydanio rerio) SS
10 20 30 40 50 60
MAPLAEVGGF LGGLEGLGQQ VGSHFLLPPA GERPPLLGER RSAAERSARG GPGAAQLAHL
70 80 90 100 110 120
HGILRRRQLY CRTGFHLQIL PDGSVQGTRQ DHSLFGILEF ISVAVGLVSI RGVDSGLYLG
130 140 150 160 170 180
MNDKGELYGS EKLTSECIFR EQFEENWYNT YSSNIYKHGD TGRRYFVALN KDGTPRDGAR
190 200 210
SKRHQKFTHF LPRPVDPERV PELYKDLLMY T